Assessing the oseltamivir-induced resistance risk and implications for influenza infection control strategies

BACKGROUND: Oseltamivir-resistant mutants with higher drug resistance rates and low trans-mission fitness costs have not accounted for influenza (sub)type viruses. Predicting the impacts of neuraminidase inhibitor therapy on infection rates and transmission of drug-resistant viral strains requires f...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsieh, Nan-Hung, Lin, Yi-Jun, Yang, Ying-Fei, Liao, Chung-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529381/
https://www.ncbi.nlm.nih.gov/pubmed/28790857
http://dx.doi.org/10.2147/IDR.S138317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529381/
https://www.ncbi.nlm.nih.gov/pubmed/28790857
http://dx.doi.org/10.2147/IDR.S138317

Ejemplares similares